MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Genetics"

  • 2022 International Congress

    Brain structure alternations and disrupted functional connectivity in paroxysmal kinesigenic dyskinesia

    Y. Liu, C. Chen, P. Wang, Y. Chen, C. Lin, S. Kwan, C. Chou, D. Yen, Y. Wu (北投區, Taiwan)

    Objective: This study aimed to delineate the morphological and functional alterations of paroxysmal kinesigenic dyskinesia (PKD) by functional magnetic resonance imaging (fMRI). Background: PKD is…
  • 2022 International Congress

    Scoring Algorithm-Based Genomic Testing in Dystonia- A Validation study from a Single Centre Cohort from India

    VV. Holla, K. Neeraja, A. Stezin, M. Netravathi, N. Kamble, R. Yadav, PK. Pal (Bengaluru, India)

    Objective: To validate a recently introduced scoring algorithm predicting the diagnostic utility of exome sequencing for dystonia. Background: Despite the increasing availability of next generation…
  • 2022 International Congress

    GLUT1 Deficiency Syndrome with Novel mutation responsive to GPi DBS

    C. Torres Vásquez, C. Zepeda Salazar, M. Rodriguez Violante, G. Cervantes Arriaga, D. Tristan, V. Cerino, T. Ortegano, A. Abundes Corona (Ciudad de mexico, Mexico)

    Objective: To describe a case of a patient with a progressive primary isolated generalized dystonia of childhood onset associated to a novel SLC2A1 mutation with…
  • 2022 International Congress

    The Spectrum of Movement Disorders Associated With NUS1 Pathogenic Variants

    NE. Mencacci, N. Prakash, E. Gerard, L. Kinsley, BK. Bölsterli, R. Steinfeld, C. Ellis, T. Tropea, T. Bardakjian, A. Lavillaureix, M. Ugolin, C. Thauvin-Robinet, M. Brugger, KM. Riedhammer, T. Opladen, T. Wirth, C. Tranchant, M. Anheim, J. Chelly, BA. Mendelsohn, S. Nandipati, A. Stembridge, HS. Dafsari, H. Zempel, P. Herkenrath, S. Mercimek-Andrews, T. Laut, J. Necpal, R. Jech, M. Zech, G. Trieschmann, S. Berweck, O. Vanakker, D. Gill, F. Gardiner, S. Mohammad, H. Mefford, I. Scheffer, G. Carvill, D. Krainc (Chicago, USA)

    Objective: To explore the phenotype of NUS1-related disorders and determine the spectrum of movement disorders in patients with NUS1 pathogenic variants. Background: A growing body…
  • 2022 International Congress

    Dopa-responsive Combined Dystonia Due to ATP1A3 Gene Variant

    M. Soares, J. Parmera, M. Bezerra (São Paulo, Brazil)

    Objective: To describe a remarkable case of a patient with an atypical ATP1A3 phenotype with levodopa responsiveness, expanding our understanding of this gene mutation. Background: The ATP1A3-spectrum disorders…
  • 2022 International Congress

    X-Linked Dystonia Parkinsonism as the cause of Isolated Lingual Dystonia (ILD)

    D. Dakay, G. Saranza, Z. Leonardo, C. Klein, N. Brüggemann, A. Westenberger (Mandaue City, Philippines)

    Objective: This report aims to describe a 43-year-old Filipino male with ILD aggravated by speech and swallowing. This paper highlights the importance of including XDP…
  • 2022 International Congress

    DHDDS and NUS1: A converging pathway and common phenotype

    L. Williams, J. Qiu, S. Waller, N. Elserafy, M. Tchan, P. Procopis, H. Sampaio, S. Mohammad, H. Morales-Briceño, V. Fung (Sydney, Australia)

    Objective: To report on the clinical spectrum of variants affecting dehydrodolichol diphosphate synthetase (DHDDS) and nuclear undecaprenyl pyrophosphate Synthase 1 (NUS1) and particularly to highlight their…
  • 2022 International Congress

    Highlighting the dystonic phenotype related to GNAO1

    T. Wirth, G. Garone, M. Kurian, A. Piton, F. Milan, A. Telegrafi, N. Drouot, G. Rudolf, J. Chelly, W. Marks, L. Burglen, D. Demailly, P. Coubes, M. Castro-Jimenez, S. Joriot, J. Ghoumid, J. Belin, J-M. Faucheux, L. Blumkin, M. Hull, M. Parnes, C. Ravelli, A. Nemeth, M. Smith, A. Barnicoat, C. Ewenczyk, A. Méneret, E. Roze, B. Keren, C. Mignot, C. Beroud, F. Acosta, C. Nowak, W. Wilson, D. Steel, A. Capuano, M. Vidailhet, J-P. Lin, C. Tranchant, L. Cif, D. Doummar, M. Anheim (Strasbourg, France)

    Objective: To characterize the clinical and genetic features of patients with mild GNAO1-related phenotype with prominent movement disorders. Background: Most reported patients carrying GNAO1 mutations…
  • 2022 International Congress

    A novel compound heterozygous PANK2 gene mutation in a South- Asian sexagenarian with atypical PKAN

    K. Pillai, B. Maramattom, S. Grover, A. Kishore (Kochi, India)

    Objective: To study the clinical course, imaging and genetics of a case of late-onset dystonia-parkinsonism suspected to have Neurodegeneration with Brain Iron Accumulation (NBIA). Background:…
  • 2022 International Congress

    De novo mutation in TMEM151A and Paroxysmal Kinesigenic Dyskinesia

    T. Wirth, A. Méneret, N. Drouot, G. Rudolf, O. Lagha-Boukbiza, J. Chelly, C. Tranchant, A. Piton, E. Roze, M. Anheim (Strasbourg, France)

    Objective: To confirm the association between TMEM151A mutation and paroxysmal kinesigenic dyskinesia. Background: Heterozygous mutations in TMEM151A, encoding a protein of undetermined function, have been…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley